Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, 10N-112, 10 Center Drive, Bethesda, MD 20892, USA.
Br J Ophthalmol. 2010 May;94(5):633-8. doi: 10.1136/bjo.2009.167940.
BACKGROUND/AIMS Diagnostic pars plana vitrectomy is a useful technique in the diagnosis of intraocular lymphoma (IOL); however, the role of transconjunctival sutureless vitrectomy (TSV) has not been fully explored for this indication. The purpose of this study was to review our experience with 25-gauge TSV for the diagnosis of IOL. METHODS Patients who underwent 25-gauge TSV for the diagnosis of IOL (primary, secondary or recurrent) from two tertiary referral centres were reviewed. Demographic data and underlying medical conditions were reviewed. Preoperative and postoperative visual acuities (VA) and ophthalmic examination data were assessed. Cytopathology, flow cytometry, cytokine and gene rearrangement studies were assessed. RESULTS Twelve patients underwent 25-gauge diagnostic TSV with a median follow-up time of 37 weeks. B-cell or T-cell IOL was diagnosed based on cytology in 3/12 patients (25%, 95% CI 8.9 to 53.2%) and in eight patients (67%, 95% CI 39.1 to 86.1%) using adjunctive diagnostic testing. VA stabilised or improved in 11 eyes (92%). Mean VA improved from 20/95 to 20/66 (p=0.055, paired t test). CONCLUSIONS 25-Gauge TSV is safe and effective for obtaining vitreous specimens for the evaluation of IOL. The availability of expert ophthalmic pathological consultation, flow cytometry, cytokine evaluation and gene rearrangement studies were essential to the diagnosis.
背景/目的 经平坦部玻璃体切除术是诊断眼内淋巴瘤(IOL)的一种有用技术;然而,对于这种适应症,经结膜无缝合玻璃体切除术(TSV)的作用尚未得到充分探索。本研究旨在回顾我们使用 25G TSV 诊断 IOL 的经验。
方法 回顾在两个三级转诊中心因 IOL(原发性、继发性或复发性)而行 25G TSV 的患者。回顾人口统计学数据和基础医学状况。评估术前和术后视力(VA)和眼科检查数据。评估细胞病理学、流式细胞术、细胞因子和基因重排研究。
结果 12 名患者接受了 25G 诊断性 TSV,中位随访时间为 37 周。根据细胞学在 3/12 名患者(25%,95%CI 8.9 至 53.2%)中诊断为 B 细胞或 T 细胞 IOL,在 8 名患者(67%,95%CI 39.1 至 86.1%)中使用辅助诊断测试诊断。11 只眼(92%)的 VA 稳定或改善。平均 VA 从 20/95 提高到 20/66(p=0.055,配对 t 检验)。
结论 25G TSV 是一种安全有效的方法,可以获得玻璃体标本用于评估 IOL。专家眼科病理咨询、流式细胞术、细胞因子评估和基因重排研究的可用性对于诊断至关重要。